Stocks in news: Cadila, Wipro, Sun Pharma, Strides, SREI

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

Choose Stock Exchange: BSE LIVE NSE LIVE

26 Aug, 2025 12:21

Volume

Todays L/H

More

×

Here are stocks that are in news today:

Results today: Asian Paints, Symphony, Bharti Infratel, Cera Sanitaryware, INOX Leisure, Kansai Nerolac, Rallis India, VIP Industries, GSFC, Cholamandalam Investment, Automotive Stampings, IG Petrochemicals, Multibase India, Omkar Speciality Chemicals, Raj Television Network, Steel Strips Wheels, Wendt (India)

Zydus Wellness Q2-Consolidated net profit up 6.6 percent at Rs 29.1 crore versus Rs 27.3 crore (YoY)-Consolidated total income up 2.2 percent at Rs 105.3 crore versus Rs 103 crore (YoY)

JSW Steel Q2-Consolidated net profit at Rs 117 crore versus Rs 748.8 crore (YoY)-Consolidated total income at Rs 10,907 crore versus Rs 13,895 crore (YoY)-Consolidated operating profit at Rs 1,729 crore versus Rs 2,812 crore (YoY)-Consolidated operating margin at 16 percent versus 20.2 percent (YoY)-Total saleable steel up 4 percent at 3.19 mt versus 3.07 mt (YoY)

Bajaj Holdings Q2-Consolidated net profit up 11.4 percent at Rs 568 crore versus Rs 510 crore (YoY)-Consolidated net sales down 40.4 percent at Rs 110 crore versus Rs 184.6 crore (YoY)

Idea Cellular Q2-Consolidated net profit down 13.1 percent at Rs 809.3 crore (QoQ)-Consolidated revenue down 1.2 percent at Rs 8,689 crore (QoQ)-Consolidated EBITDA down 5.3 percent at Rs 3,057 crore (QoQ)-Consolidated EBITDA margin at 35.2 percent versus 36.7 percent (QoQ)-Volume at 189.5 billion minutes versus 195.8 billion minutes (QoQ)-Voice rate at 32.70p/min versus 32.90p/min (QoQ)

Delta Corp Q2-Consolidated net profit at Rs 6.4 crore versus loss of Rs 3.5 crore (YoY)-Consolidated total income up 23.2 percent at Rs 93.6 crore versus Rs 76 crore (YoY)

Akzo Nobel Q2-Net profit up 15 percent at Rs 41 crore versus Rs 36 crore (YoY)-Revenue up 8 percent at Rs 657 crore versus Rs 607 crore (YoY)

Wipro Q2-IT services rupee revenue at Rs 12,042.8 crore versus Rs 11,577 crore (QoQ)-IT services dollar revenue at USD 1,831.9 million versus USD 1,794.1 million (QoQ)-IT services EBITDA margin at 20.7 percent versus 21 percent (QoQ)-Non-GAAP constant currency IT services dollar revenue up 3.1 percent QoQ & 8.4 percent YoY-Wipro guidance: Expect Q3FY16 IT services dollar revenue in range of USD 1,841-1,878 millionWipro says-Added 67 new customers in Q2-Energy business impacted by lower commodity prices delivered flat earnings-See stable demand environment going forward-Number of multi-USD 100 million deals has come down-Digital business shows strong traction with 7 deal wins in Q2-Weakness in OEM space will continue-Launched a focussed programme to train 10,000 employees in digital-Q3 guidance impacted by high furloughs, less working days & slow ramp-up in deals won

Cairn India Q2-Consolidated net profit down 19.4 percent at Rs 672.7 crore versus Rs 835 crore (QoQ)-Consolidated total income down 14.7 percent at Rs 2,242 crore versus Rs 2,627 crore (QoQ)-Consolidated EBITDA down 29.4 percent at Rs 911 crore versus Rs 1,290 crore (QoQ)-Consolidated EBITDA margin at 40.6 percent versus 49.1 percent (QoQ)-Forex gain of Rs 381 crore versus Rs 182 crore (QoQ)-Tax credit at Rs 180 crore versus deferred tax of Rs 58 crore (QoQ)-Cairn India says optimistic on meeting production projections for FY16

KPIT Tech Q2-Consolidated net profit up 69.1 percent at Rs 75.1 crore versus Rs 44.4 crore (QoQ)-Consolidated income from operations up 7.1 percent at Rs 812.2 crore versus Rs 758.3 crore (QoQ)

Tata Coffee Q2-Consolidated net profit down 15.1 percent at Rs 27.5 crore versus Rs 32.4 crore (YoY)-Consolidated total income up 2.8 percent at Rs 452.6 crore versus Rs 440.4 crore (YoY)

Blue Dart Q2-Net profit up 74.4 percent at Rs 53.7 crore versus Rs 30.8 crore (YoY)-Total income up 12 percent at Rs 651.5 crore versus Rs 581.7 crore (YoY)

HCL Infosystems Q2-Consolidated net loss at Rs 49.2 crore versus loss of Rs 41.4 crore (QoQ)-Consolidated net sales down 12.7 percent at Rs 1,470.6 crore versus Rs 1,685.5 crore (QoQ)

Cadila Healthcare Q2-Consolidated net profit at Rs 391 crore versus Rs 278 crore (YoY)-Consolidated net sales at Rs 2,418 crore versus Rs 2,064 crore (YoY)

SSIPL Retail files DRHP; IPO includes fresh issue of shares worth Rs 72 croreSSIPL Retail says-Some existing shareholders will also sell shares in IPO-Axis Capital & Ambit Corporate are book running lead managers for IPO

American Tower Corp announces acquisition of controlling stake in Viom NetworksATC-Viom deal: ATC says-Total cash consideration for Viom Networks’ deal will be Rs 7,600 crore-Will acquire a 51 percent controlling interest in Viom Networks-Under agreement, may acquire all or portion of remaining 49 percent stake in Viom-At closing, Tata Teleservices to retain part of holding-Viom deal is expected to close in mid-2016-Macquarie SBI Infra Investment, SBI Macquarie Infra Trust & IDFC Private Equity to retain certain stake-Post-closing, ATC’s existing Indian portfolio of approximately 14,000 towers to be merged with Viom

ATC-Viom deal: SREI Infra to CNBC-TV18-Signed definitive agreement with ATC-Viom enterprise value of around Rs 23,000 crore, debt of approximately Rs 6,000 crore-Company gets Rs 3,000 crore in cash including non-compete fee-Will use sale proceeds for core business expansion-Will use sale proceeds primarily for infra financing business-Post merger, Tata Teleservices to hold 26 percent stake-Macquarie’s 11 percent stake will get diluted-Hope to get FIPB & CCI approvals for the deal soon

Sun Pharma says-Company enters into settlement agreement with Acorda Therapeutics-Settlement agreement with Acorda to resolve a pending patent litigation-To resolve patent litigation involving Ampyra extended-release tablets in US-Will be permitted to market a generic version of Ampyra in US in 2027-Will submit agreement to US Federal Trade Commission & Dept Of Justice

Strides Arcolab-Acquires 7 brands from Johnson & Johnson-Acquires majority stake in domestic business of MedispanStrides Arcolab says-Acquired portfolios have combined revenue potential of Rs 32 crore in FY16-Brand acquisitions to strengthen India branded business

Government imposes anti-dumping duty on import of various itemsGovernment says-Items include plain medium density fibre board of thickness 6 mm & above-Items include front axle beam & steering knuckles for M&HCVs Orange CFO says-Due diligence on deal to buy assets in Africa from Bharti Airtel ongoing, aims for decision by year-end -Reasonably confident about 2016 prospects, confirm this year will be low-point for core profit

DLF-Appoints JPMorgan & Morgan Stanley as bankers for sale of 40 percent stake in arm DLF Cybercity Developers-DLF deal is estimated at Rs 12,000 crore: Sources

Reliance Communications-In talks with BSNL, Vodafone, Idea for 3G-ICR (intra-circle roaming) like 2G deal:-To roll out a 3G ICR-like roaming agreement in Bihar, West Bengal, Assam: PTI

Other stocks and sectors that are in news today:-Corporation Bank, GIC Housing Finance likely to buyout Nomura’s 35 percent stake in LIC Mutual Fund-Tata Steel, Sure Safety tie up for Odisha defence plant: ET-Coffee Day Enterprises IPO issue price at Rs 328/share: Reuters-Max India says board to consider proposal regarding its existing arrangements with Axis Bank as a shareholder of Max Life on October 23-Thomas Cook to consider issue of non-convertible redeemable preference shares on private placement basis-Maruti hikes wages of temporary workers by 10 percent: PTI-RBI says FIIs/RFPIs can invest up to 74 percent in Shriram Transport Finance-Speciality Restaurants: BMC orders for closure company's restaurant due to non-production of required documents-Petronet LNG pays Rs 400 crore demurrage as PSUs refuse costly gas import-Central Vigilance Commission seeks report from CBI, Bank Of Baroda on Rs 6,100 crore forex scam: PTI-Aditya Birla Chemicals shareholders approve raising up to Rs 1,200 crore via private placement-Aurobindo Pharma gets US FDA nod for pain killer Tramadol hydrochloride-Lupin gets tentative US FDA nod for Milnacipran hydrochloride (an antidepressant drug)